Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HASPIN | Q8TF76 | 5/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | HIPK2 | Q9H2X6 | 3/20 | 0.41 |
| ▸ | CLK1 | P49759 | 2/20 | 0.40 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.37 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.37 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.37 |
| ▸ | CHUK | O15111 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3589139 | 0.87 | HASPIN (0.54) | HASPINGSK3BCLK1DAPK3PLK1 | |
| SCHEMBL8706865 | 0.80 | ESR1 (0.48) | HASPINGSK3BHIPK2CLK1DAPK3 | |
| SCHEMBL22445531 | 0.80 | HASPIN (0.47) | HASPINGSK3BHIPK2CLK1DAPK3 | |
| SCHEMBL31614113 | 0.80 | HASPIN (0.47) | HASPINGSK3BHIPK2CLK1DAPK3 | |
| SCHEMBL11090929 | 0.77 | TDP1 (0.46) | HASPINGSK3BHIPK2CHUKMEN1 | |
| SCHEMBL11738139 | 0.76 | NCOA3 (0.44) | HASPINGSK3BHIPK2CLK1DAPK3 | |
| SCHEMBL11742334 | 0.76 | HASPIN (0.44) | HASPINGSK3BHIPK2CLK1DAPK3 | |
| SCHEMBL3699674 | 0.75 | TSHR (0.62) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3697120 | 0.75 | HPRT1 (0.56) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3776997 | 0.75 | HPRT1 (0.56) | TSHRMEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0074741-B1 | METHOD OF PRODUCING ALPHA2 ANTAGONISM | SMITHKLINE BECKMAN CORPORATION (US) | 1986-11-12 | — | — | EP | disclosed |
| EP-0023761-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM | SMITHKLINE BECKMAN CORPORATION (US) | 1984-03-07 | — | — | EP | disclosed |
| EP-0074741-A1 | Method of producing alpha2 antagonism | SMITHKLINE BECKMAN CORPORATION (US) | 1983-03-23 | — | — | EP | disclosed |
| US-4352809-A | THIADIAZOLO- AND OXADIAZOLOTETRAHYDROISOQUINOLINES, ANTIDEPRESSANTS | SMITHKLINE CORPORATION (US) | 1982-10-05 | — | — | US | disclosed |
| US-4258049-A | Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines | SMITHKLINE CORPORATION (US) | 1981-03-24 | — | — | US | disclosed |
| EP-0023761-A1 | Tetrahydroisoquinoline derivatives, process for preparing them and compositions containing them | SMITHKLINE BECKMAN CORPORATION (US) | 1981-02-11 | — | — | EP | disclosed |
| US-4062961-A | SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINES | SMITHKLINE CORPORATION (US) | 1977-12-13 | — | — | US | disclosed |
| US-3988339-A | 7 OR 8-SUBSTITUTED 1,2,3,4-TETRAHYDRO-ISOQUINOLINE | SMITHKLINE CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |